Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences

Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017

The association of psychedelic use and opioid use disorders among illicit users in the United States

Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. | Journal of Psychopharmacology | 14 February 2017

An online survey of tobacco smoking cessation associated with naturalistic psychedelic use

Johnson, M. W., Garcia-Romeu, A., Johnson, P. S., & Griffiths, R. R. | Journal of Psychopharmacology | 18 January 2017

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Treating drug dependence with the aid of ibogaine: A qualitative study

Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?

Sessa, B. | Journal of Psychedelic Studies | 30 December 2016

The antiaddictive effects of ibogaine: A systematic literature review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016

A One-Dose Psychedelic Fix for Addiction?

Jacobson, R. | Scientific American Mind | 8 December 2016

Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration

Aarde, S. M., & Taffe, M. A. | Current Topics in Behavorial Neuroscience | 2 December 2016

Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., & Forcehimes, A. A. | Journal of Humanistic Psychology | 16 October 2016

The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment

Skocylas, R. | UBC Medical Journal | 1 September 2016

Psilocybin for treating substance use disorders?

de Veen, B. T., Schellekens, A. F., Verheij, M. M., & Homberg, J. R. | Expert Review of Neurotherapeutics | 12 August 2016

Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study

Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016

Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics

Tófoli, L. F., & de Araujo, D. B. | International Review of Neurobiology | 25 July 2016

Long-term follow up of psilocybin-assisted smoking cessation

Garcia-Romeu, A. P., , Griffiths, R. R., & Johnson, M. W. | The American Journal of Drug and Alcohol Abuse | 21 July 2016

Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report

Chang, H., Huang, M. C., & Chen, L. Y. | The Primary Care Companion for CNS Disorders | 23 June 2016

Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors

Ponzoni, L., Daniela, B., & Sala, M. | Psychopharmacology | 16 June 2016

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. | Journal of Psychopharmacology | 10 June 2016

Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users

Davis, A. K., & Rosenberg, H. | Psychology of Addictive Behaviors | 1 June 2016

Ibogaine and addiction in the animal model, a systematic review and meta-analysis

Belgers, M., Leenaars, M., Homberg, J. R., Ritskes-Hoitinga, M., Schellekens, A. F. A., & Hooijmans, C. R. | Translational psychiatry | 31 May 2016